IL6 and Sepsis: A randomized clinical study showed that prior statin use was associated with a lower baseline plasma IL-6 in patients with severe sepsis and improved 28-day survival, and the authors hypothesized that pretreatment with statins in critically ill patients at risk of sepsis may be more effective than treating established sepsis [24].